Do the Trajectories of Dyspnea Differ in Prevalence and Intensity By Diagnosis at the End of Life? A Consecutive Cohort Study David C. Currow, BMed, MPH, FRACP, Joanna Smith, BPsych, Patricia M. Davidson, BA, MEd, PhD, Phillip J. Newton, BN (Hons), PhD, Meera R. Agar, MBBS (Hons), M Pall Care, FRACP, FAChPM, Amy P. Abernethy, MD Journal of Pain and Symptom Management Volume 39, Issue 4, Pages 680-690 (April 2010) DOI: 10.1016/j.jpainsymman.2009.09.017 Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions
Fig. 1 Percentage of people with no, mild, moderate, or high dyspnea scores in a consecutive cohort of people referred to a community palliative care service as death approaches (n=5,862). Journal of Pain and Symptom Management 2010 39, 680-690DOI: (10.1016/j.jpainsymman.2009.09.017) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions
Fig. 2 Joinpoint regression model of mean Symptom Assessment Scale (SAS) score of breathlessness by cancer and noncancer diagnoses at the approach of death in a consecutive cohort of 5,862 community palliative care patients. Journal of Pain and Symptom Management 2010 39, 680-690DOI: (10.1016/j.jpainsymman.2009.09.017) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions
Fig. 3 Changes in the mean intensity of breathlessness in five diagnostic groups as death approaches in a consecutive community cohort of people referred to palliative care (n=5,862). Journal of Pain and Symptom Management 2010 39, 680-690DOI: (10.1016/j.jpainsymman.2009.09.017) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions